Community-acquired febrile urinary tract infection in diabetics could deserve a different management: A case-control study

Journal of Internal Medicine

Volumn 254, Issue 3, 2003, Pages 280-286

  Horcajada, Juan P ^a   Moreno, I ^a   Velasco, M ^a   Martinez J A ^a   Moreno Martinez A ^a   Barranco, M ^a   Vila, J ^a   Mensa, J ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Case control study; Diabetes; Febrile urinary tract infection

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CASE CONTROL STUDY; CITROBACTER; COMMUNICABLE DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; ESCHERICHIA COLI; FEMALE; FEVER; HUMAN; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEUS MIRABILIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION;

AGED; CASE-CONTROL STUDIES; COMMUNITY-ACQUIRED INFECTIONS; DIABETES COMPLICATIONS; FEMALE; FEVER; HUMANS; MALE; PROSPECTIVE STUDIES; URINARY TRACT INFECTIONS;

EID: 0042830407     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2003.01197.x     Document Type: Article

References (26)

1. Patterson JE, Andreoli VT. Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am 1997; 11: 735-50.
2. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patiens with diabetes mellitus. N Engl J Med 1999; 341: 1906-12.
3. Nicolle LE, Friesen D, Harding GKM, Roos LL. Hospitalization for acute pyelonephritis in Manitoba, Canada, during the period from 1989 to 1992: impact of diabetes, pregnancy, and aboriginal origin. Clin Infect Dis 1996; 22: 1051-6.
4. Bonadio M, Meini M, Gigli C, Longo B. Urinary tract infection in diabetic patients. Urol Int 1999; 63: 215-9.
5. Wright SW, Wrenn KD, Haynes M, Haas DW. Prevalence and risk factors for multidrug resistant uropathogens in ED patients. Am J Emerg Med 2000; 18: 143-6.
6. Garau J, Xercavins M, Rodriguez-Carballeira M et al. Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother 1999; 43: 2736-41.
7. Goettsch W, van Pelt W, Nagelkerke N et al. Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands. J Antimicrob Chemother 2000; 46: 223-8.
8. Deguchi T, Kawamura T, Yasuda M et al. In vivo selection of Klebsiella pneumoniae strains with enhanced quinolone resistance during fluoroquinolone treatment of urinary tract infections. Antimicrob Agents Chemother 1997; 41: 1609-11.
9. Nakano M, Yasuda M, Yokoi S, Takahashi Y, Ishihara S, Deguchi T. In vivo selection of Pseudomonas aeruginosa with decreased susceptibilities to fluoroquinolones during fluoroquinolone treatment of urinary tract infection. Urology 2001; 58: 125-8.
10. Wahl PW, Savage PJ, Psaty BM, Orchard TJ, Robbins JA, Tracy RP. Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet 1998; 352: 1012-5.
11. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2002; 25 (Suppl. 1): S5-20.
12. Meyer JS, Rauch G, Rauch RA, Haque A. Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia. Neurobiol Aging 2000; 21: 161-9.
13. MacFarlane IA, Brown RM, Smyth RW, Burdon DW, FitzGerald MG. Bacteraemia in diabetics. J Infect 1986; 12: 213-9.
14. Carton JA, Maradona JA, Nuno FJ, Fernandez-Alvarez R, Perez-Gonzalez F, Asensi V. Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients. Eur J Med 1992; 1: 281-7.
15. Bryan CS, Reynolds KL, Metzger WT. Bacteremia in diabetes patients: comparison of incidence and mortality with non-diabetic patients. Diabetes Care 1985; 8: 244-9.
16. Delamaire M. Impaired leucocyte functions in diabetic patients. Diabet Med 1997; 14: 29-34.
17. Geerlings SE, Brouwer EC, van Kessel KC, Gaastra W, Stolk RP, Hoepelman AI. Cytokine secretion is impaired in women with diabetes mellitus. Eur J Clin Invest 2000; 30: 955-1001.
18. Zhanel GC, Nicolle LE, Harding GKM and the Manitoba Diabetic Urinary Infection Study Group. Prevalence of asymptomatic bacteriuria and associated host factors in women with diabetes mellitus. Clin Infect Dis 1995; 21: 316-22.
19. Ingberg CM, Palmer M, Schvarcz E, Aman J. Prevalence of urinary tract symptoms in long-standing type 1 diabetes mellitus. Diabetes Metab 1998; 24: 351-4.
20. Kaplan SA. Vesical disfunction. In: Lebovitz HE, ed. Therapy for Diabetes Mellitus and Related Disorders. Alexandria: American Diabetes Association. 1994; 275-8.
21. Forland M. The treatment of urinary tract infections in women with diabetes mellitus. Diabetes Care 1985;8:499-506.
22. Lye WC, Cahn RK, Lee EJC, Kumarasinghe G. Urinary tract infections in patients with diabetes mellitus. J Infect 1992; 24: 169-74.
23. Geerlings SE, Stolk RP, Camps MJL et al. Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Care 2000; 23: 744-9.
24. Horcajada JP, Vila J, Moreno-Martínez A et al. Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis. J Antimicrob Chemother 2002; 49: 55-9.
25. Velasco M, Horcajada JP, Mensa J et al. Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections. Clin Infect Dis 2001; 33: 1682-6.
26. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999; 29: 745-58.